Evidence map›Paper›PMID 31312725›Full record

ArticleCommunications biology2019

High-Throughput Yeast Aging Analysis for Cryptococcus (HYAAC) microfluidic device streamlines aging studies in

Erika P Orner, Pengchao Zhang, Myeong C Jo, Somanon Bhattacharya, Lidong Qin, Bettina C Fries

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. The power of many: when genetics met yeasts and high-throughput.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  2. Mitochondrial cardiolipin sequestration of caspofungin underliesbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Measuring Replicative Lifespan in Cryptococcus neoformans.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Replicative Aging in Pathogenic Fungi.Journal of fungi (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Erika P Orner1Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794 USA.ORCID 0000-0002-6253-7298
Pengchao Zhang2Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030 USA.
Myeong C Jo2Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030 USA.
Somanon Bhattacharya4Department of Medicine, Stony Brook University, Stony Brook, NY 11794 USA.ORCID 0000-0002-8562-3877
Lidong Qin2Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX 77030 USA.
Bettina C Fries1Department of Molecular Genetics and Microbiology, Stony Brook University, Stony Brook, NY 11794 USA.ORCID 0000-0002-6847-5518
Houston Methodist · USStony Brook University · USNorthport VA Medical Center · US

Funding

Rapid production of SARS-CoV-2 molecular clones using CRISPR-based yeast recombineeringR01AI100272 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MADHANI, HITEN D · 2012 to 2025
$11.3M
MOLECULAR AND CELL BIOLOGY OF INFECTIOUS DISEASEST32AI007539 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI KONOPKA, JAMES B · 1998 to 2023
$3.6M
response to phenotypic switch variants to C. neoformansR01AI059681 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2004 to 2014
$3.6M
Investigation on Replicative aging in Cryptococcus neoformans populationsR01AI127704 · NIAID · STATE UNIVERSITY NEW YORK STONY BROOK · PI FRIES, BETTINA · 2017 to 2021
$3.2M
Scholars in BioMedical Sciences (SBMS) Training ProgramT32GM127253 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI TSIRKA, STYLIANI-ANNA (STELLA) E · 2018 to 2022
$689k
BLRD VA I01 BX003741NIAID NIH HHS R01 AI059681NIAID NIH HHS R01 AI100272NIAID NIH HHS R01 AI127704NIAID NIH HHS T32 AI007539NIGMS NIH HHS T32 GM127253
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lab-On-A-Chip DevicesAmphotericin BAntifungal AgentsAnti-Infective AgentsCryptococcus neoformansDrug Resistance, MicrobialMicrodissectionMicrofluidicsPhenotypeRNASaccharomyces cerevisiaeUp-RegulationVirulenceAmphotericin BAntifungal AgentsAnti-Infective AgentsRNAAntimicrobial resistanceFungal pathogenesisLab-on-a-chip

Identifiers

PMID31312725
PMCPMC6620289
OpenAlexW2962391048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.